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Model membraneGL13K is a short (13 amino acid) antimicrobial peptide derived from the parotid secretory protein. GL13K has been
found to exhibit anti-inﬂammatory and antibacterial activities in physiological salt conditions.We investigated the
mechanism of interaction of GL13K, withmodelmembranes comprising 1, 2-dioleoylphosphatidylcholine (DOPC)
and 1, 2-dioleoylphosphatidylglycerol (DOPG) using various biophysical and imaging techniques. Circular dichro-
ism studies showed that GL13K adopts a β-sheet structure in the presence of negatively charged DOPG liposomes
while it retains its random coil structure with zwitterionic DOPC liposomes. GL13K did not cause any fusion of
these liposomes but was able to selectively disrupt the negatively charged membranes of DOPG leading to vesic-
ular leakage. Therewas no orminimal evidence of GL13K interactionwithDOPC liposomes, however an analysis of
supported lipid bilayers (SLBs) using atomic force microscopic (AFM) imaging and dual polarization interferome-
try (DPI) suggested that GL13K can interact with the surface of a DOPC planar bilayer. In the case of DOPG bilayers,
AFM and DPI clearly showed membrane thinned regions where a portion of lipid molecules has been removed.
These results suggest that the mechanism of GL13K action on bacterial membranes involves localized removal
of lipid from the membrane via peptide-induced micellization.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The discovery of penicillin in the 1940s led to the beginning of an
“antibiotic era” enabling treatment of life threatening infections which
was not possible before. Since then, the development of new and effec-
tive antibioticsmade it possible to curemany fatal bacterial ormicrobial
diseases. However, in recent decades the extensive and improper use of
antibiotics has resulted in the emergence of new highly resistant bacte-
rial strains and thus leading towards a “post antibiotic era” where we
will have only few antibiotics left to combat multidrug resistant bacte-
rial strains [1–3]. According to a recent report published by the World
Health Organization [4], in this post-antibiotic era, the development of
new effective antibiotic drugs has been diminished which has in-
creased and prolonged illnesses leading to increased mortality rates
and socio-economic burden on societies especially in developing na-
tions. The most severe forms of bacterial infections are caused by
Gram-negative bacteria and their bioﬁlms, including Pseudomonas
and Acinetobacter [5,6]. Bacterial bioﬁlms are several folds more re-
sistant to antibiotics compared to their planktonic (ﬂoating) state [7–9].ual polarization interferome-
ide/lipid ratio; TM, Transverse
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rights reserved.Antimicrobial peptides (AMPs) seem to be potent antibiotic candi-
dates. AMPs are part of the innate immune system in most organisms
(plant/animal kingdoms) [10]. Various bacteria, despite encountering
these AMPs for millions of years, have not been able to develop resis-
tance [11,12]. AMPs do not act via a stereospeciﬁc protein receptor
mediated mechanism but rather target the fundamental difference in
membrane composition between the host and the pathogens [12,13].
Bacteria are less able to develop resistance against AMPs by redesigning
their membrane since changing membrane composition and/or lipid
organization is not metabolically favorable due to limited membrane
lipid synthesis capabilities [1]. This has attracted many researchers to
exploit these AMPs and their synthetic analogs as novel antibiotics
and an extensive database of almost 2000 known and potential AMPs
(antibacterial, antiviral, antifungal and antitumor) has been established
[14].
AMPs are reported to actmainly by causingmembrane lysis either by
barrel stave, toroidal pore or carpet mechanisms though various other
mechanisms are also observed [10,15,16]. No single mechanism can be
deﬁned for all peptides [17]. Furthermore,membrane disruptionmecha-
nisms for a given peptide can vary depending on lipid composition or
other environmental conditions, for example melittin and aurein were
found to act by three different mechanisms (barrel stave, toroidal pore
and carpet) depending on the conditions used [18–21]. The interaction
of AMPs with membranes can involve a variety of processes including
the disruption of peptide aggregates, binding to the membrane surface,
secondary structure transformation, reorientation into the membrane,
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ty and eventually lysis of the membrane.
It is well accepted that electrostatic interactions can play a major
role in the activity and speciﬁcity of AMPs notwithstanding the signiﬁ-
cant roles of hydrophobic forces, membrane curvature and mechanical
properties. Despite differences in mechanisms, it can be concluded
that AMPs act mainly by binding to membranes and kill bacteria by
disrupting membrane packing and organization causing defects in the
membrane with the consequent destruction of transmembrane poten-
tial and leakage of important cellular contents [12,22].
GL13K is a small cationic AMP, which was designed by a modiﬁ-
cation of a peptide sequence derived from human parotid secretory
protein (hPSP) [23]. PSP is predicted to be structurally similar to
bactericidal/permeability-increasing protein and lipopolysaccharide-
binding protein [24]. This predicted structural similarity of PSP was
used to identify potential antimicrobial peptides in the PSP sequence
[23,25]. One of the resulting peptides, GL13NH2, induced bacterial
agglutination but was not bactericidal [25]. To produce GL13K, the
GL13NH2 peptide wasmodiﬁed by introducing three lysine residues,
which switched the activity from agglutinating to bactericidal [25]. Both
peptides exhibit anti-lipopolysaccharide activity [23,26,27]. Themodiﬁed
peptide, GL13K, comprises 13 amino acids (GKIIKLKASLKLL-CONH2) and
carries a net charge of +5 at pH-7 as calculated using the Innovagen on-
line peptide property calculator [28]. GL13Khas strong anti-inﬂammatory
and antibacterial activities against both Gram-negative and bioﬁlm
forming bacteria but exhibits low hemolytic and cytotoxic activities.
Also, like polymyxin B, GL13K binds lipopolysaccharide [26], a com-
ponent of the outer bacterial membrane. Of particular note, GL13K
has been found to be effective against the Gram-negative bacterium
Pseudomonas aeruginosa. These opportunistic pathogens are associ-
ated with infections and bioﬁlm formation in susceptible individ-
uals, including nosocomial infections and cystic ﬁbrosis patients
[29].
Herein we present the biophysical studies to understand the mem-
brane disruptionmechanism for GL13K. Bacterial membranes are highly
anionic in nature whereas outer leaﬂets of eukaryotic membranes tend
to be neutral [30–32]. Therefore, we chose zwitterionic DOPC and anion-
ic DOPG lipids as models for eukaryotic and bacterial membranes,
respectively, to elucidate the effect of electrostatic interactions on the
activity and speciﬁcity of GL13K.2. Materials and methods
2.1. Materials
Lipids were obtained from Avanti Polar Lipids, Inc. (Alabaster, AL,
USA). 5-(and-6)-Carboxyﬂuorescein (CF) mixed isomers were supplied
by Molecular Probes (Eugene, OR, USA) and used as the sodium salt of
CF, obtained by neutralization with two molar sodium hydroxide. The
peptide GL13K was obtained from the University of Minnesota pep-
tide synthesis facility at better than 95% purity as evidenced by
HPLC and mass spectrometry [26]. The peptides were supplied as
lyophilized triﬂuoroacetate salts. Stock solutions were prepared in
water and then diluted in appropriate buffer. Sephadex G-50 (ﬁne
with a bead size of 20–80 μm, ACS grade), sodium phosphate mono-
basic monohydrate (NaH2PO4 · H2O), sodium hydrogen phosphate
heptahydrate (Na2HPO4 · 7H2O), 4-(2-hydroxyethyl) piperazine-1-
ethanesulfonic acid (HEPES), sodium hydroxide (NaOH) and sodium
chloride (NaCl) were obtained from Sigma-Aldrich. Unless otherwise
stated, all experiments were conducted in 10 mM sodium phosphate
buffer at pH 7.4 (“sodium phosphate”) in this report prepared from
NaH2PO4 · H2O and NaH2PO4 · 7H2O. HEPES buffer was prepared by
dissolving the desired amount of HEPES in water and adjusting the
pH to 7.4 using NaOH. In all cases ultrapure water (18.2 MΩ cm
resistivity) was used.2.2. Liposome preparation
Liposomes were prepared by extrusion as described by Mayer et al.
[33] using amini-extruder supplied byAvanti Polar Lipids Inc. (Alabaster,
AL, USA). The desired lipid was dissolved in chloroform and the solvent
removed under vacuum for 40 min to yield a thin ﬁlm of lipid. The
dried ﬁlms were hydrated using the desired buffer at room temperature
for 2 h and then vortexed at high speed for 10 min resulting in the for-
mation of multi lamellar vesicles. These vesicles were then extruded 41
times at room temperature through 0.1 μm size nucleopore polycarbon-
ate membranes mounted in a mini-extruder in order to ensure lipo-
somes of low polydispersity.
2.3. Isothermal titration calorimetry (ITC)
The thermodynamic parameters for the interaction of peptide
with DOPG and DOPC liposomes were studied using a VP-ITC Micro-
calorimeter (MicroCal Inc., Northampton, MA, USA). All solutions were
degassed for 30 min under a vacuum with continuous stirring before
loading the reaction chamber and syringe. In one set of experiments,
4 μl of 1 mM DOPC or DOPG liposomes were injected sequentially
into 0.1 mM GL13K contained in the reaction cell. A stirring speed
of 300 rpmwith injection periods of 8 s were chosenwith an equilibra-
tion time of 4 min between each injection to ensure proper mixing and
a stable baseline. In another set of experiments, 3 μl of 1 mM GL13K
were injected sequentially into 0.1 mM DOPG liposomes contained in
the reaction cell while all other parameters remained the same. These
experiments were carried out in sodium phosphate buffer in the pres-
ence or absence of 107 mM NaCl (as indicated) to study the effect of
charge shielding on GL13K binding parameters. All experiments were
performed at 22 °C. Data analysis was performed using MicroCal
Origin® 5.0 software. Diminished heat signals observed after the
system reached saturation were used to correct for the heat of dilu-
tion. The binding site model was chosen based on best mathemati-
cal ﬁt rather than a mechanistic model as the binding of AMPs with
membranes is not due to a speciﬁc binding/receptor site.
2.4. Circular dichroism (CD)
CD spectrawere recorded using a J-815 spectrometer (Jasco Corpora-
tion, Essex, UK) as an average of 5 scans obtained using a 0.2 cm path
length quartz cuvette at 22 °C from 200 nm to 260 nm with data pitch
0.2 nm, scan speed 20 nm/min and a response time of 1 s. All spectra
were corrected by subtraction of the buffer spectra. We were not able
to record below 200 nm due to high tension voltage value going above
600 V leading to low signal to noise ratio. Spectra for GL13K in the pres-
ence or absence of liposomeswere obtained at aﬁxed peptide concentra-
tion of 60 μM with varying lipid concentrations to obtain peptide/lipid
ratios (P/L) ranging from 1/15 to 1/2.5. All spectra were corrected for
path length and concentration to give the mean residue ellipticity.
2.5. Carboxyﬂuorescein (CF) release assay
Liposomal leakage caused by GL13K was studied by following the
release of CF encapsulated at high concentration in the core of lipo-
somes [34,35]. CF is self-quenched when entrapped in the liposome
core [36]. Membrane disruption leading to the release of CF yields an in-
crease in ﬂuorescence intensity. Liposomes for CF assays were prepared
by hydrating the dried ﬁlm with 50 mM CF in 10 mM HEPES buffer
at pH-7.4 and extruded as explained in Section 2.2. Non-encapsulated
CF was separated from CF encapsulating liposomes using a Sephadex
G-50 columnwith 10 mMHEPES, 107 mMNaCl at pH-7.4 as an eluent.
The lipid concentrationwas determined using phosphate analysis based
on the method by Bartlett et al. [37]. CF leakage experiments were
recorded using a Varian Cary Eclipse spectrophotometer (Agilent Tech-
nologies Inc., Mississauga, ON, Canada) equipped with a Varian Cary
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citation and emissionwavelengths were set to 480 nm and 520 nm, re-
spectively. All experiments were performed at a ﬁxed phospholipid
concentration of 25 μM. After recording the intensity for 2 min, an ali-
quot of GL13K was added to achieve the desired P/L ratio and the ﬂuo-
rescence was monitored for 60 min. Triton X-100, known to cause
complete loss of membrane integrity, was used as a control for 100%
lysis.
2.6. Dynamic light scattering (DLS)
The hydrodynamic radius of the liposomes was measured by DLS
using a Zetasizer Nano-S (Malvern Instruments Ltd, Worcestershire,
UK). All experiments were carried out at a ﬁxed lipid concentration of
25 μM with P/L lipid ratios varying from 1/20 to 1/2.5 with 10 min
equilibration time. For each experiment, 5 measurements comprising
20 runs each averaged over 20 s were recorded. For each P/L ratio, ex-
periments were repeated at least three times with different batches of
liposomes.
2.7. Dual polarization interferometry (DPI)
An AnaLight BIO200 interferometer from FarField Group Ltd.
(Manchester, UK) was used to study the interaction mechanism of
GL13K with supported lipid bilayers (SLBs) of DOPC or DOPG. DPI is
an analytical technique that uses dual optical waveguide interferometry
for analyzing thin ﬁlms [38–43] and enables real time measurement of
changes in thickness, refractive index, mass and birefringence of an
adsorbed layer on the sensor chip.
An unmodiﬁed AnaChip™ FB 80 from FarField Group Ltd.
(Manchester, UK) with dimensions 24 × 6 mm was used to measure
changes in the adsorbed bilayer. A 100 μm thick ﬂuorosilicone mask
was clamped on the chip to form two microﬂuidic ﬂow channels of
1 × 17 mm offering a channel volume of 1.7 μl. The sensor chip was
then ﬁxed in a dual zone temperature controlled housing maintained
at a temperature of 22 °C by a Peltier system. The ﬂow rate through
the two channels on the chip surface was controlled using a Harvard
Apparatus PHD2000 supplied by FarField.
SLBs on two sensor channels of chip were formed by vesicular rup-
ture by calcium ions according to the method of Mashaghi et al. [42].
Divalent calcium helps in bilayer formation by enabling the fusion of
liposomes by diminishing repulsive hydration forces and electrical
forces between liposomes [44]. DOPG and DOPC liposomes 200 μM
in 10 mM HEPES, 2 mM CaCl2 at pH-7.4 were injected at 10 μl/min
for 20 min leading to formation of the SLB. The bilayer was further
equilibrated with ﬂowing buffer without calcium and allowed to stabi-
lize for at least an hour until stable values for transversemagnetic (TM)
phase and transverse electric (TE) phase were obtained (i.e., no or
minimal change in mass, thickness and birefringence). GL13K was
injected consecutively on the same bilayer with increasing concen-
trations (1 μM, 2 μM, 4 μM, 6 μM, 8 μM, 10 μM, 12 μM and 14 μM)
at a 20 μl/min ﬂow rate for 10 min with an equilibration time of 20 min
between each injection. Data acquisition was done using AnaLight® ver-
sion 2.1.21 software and analyzed using AnaLight® explorer software.
Phase changes in TM and TE are ﬁtted to calculate the thickness,
mass and refractive index of the system. Anisotropic adlayers such as bi-
layers have different refractive indices perpendicular and parallel to the
optical axis known as ordinary (no) and extraordinary refractive (ne) in-
dices [39]. The difference between ne and no is the birefringence which
is related directly to the ordering of the system whereby a decrease in
birefringence indicates decreased ordering [38,40,41,45–47]. Birefrin-
gence is calculated as a difference in effective refractive index (nTM)
and (nTE) measured by TM and TE respectively. To calculate the bilayer
parameters such as thickness, refractive index (R.I.), mass and birefrin-
gence either the thickness or R.I. must be known. Herein a ﬁxed isotro-
pic R.I. value of 1.47 was used [40,46].Mass values for the adlayer can be calculated using the de Feijter
formula:
Eq. (1) Mass of adlayer
m adlayerð Þ ¼ d niso−nbufferð Þ
dn
dc
 
niso ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
n2TM þ n2TE
3
s
where niso is the average isotropic refractive index of the adlayer, nbuffer is
the refractive index of the buffer and dn/dc is the speciﬁc refractive index
increment for the adlayer. In general, the peptide and lipid dn/dc values
are taken to be 0.182 mL/g and 0.135 mL/g, respectively [38,42]. As
dn/dc values speciﬁc for peptide–lipid complexes are not known,
there is a high degree of uncertainty in the calculated mass changes,
therefore only changes in birefringence of DOPG and DOPC bilayers
upon interaction with GL13K will be discussed.
2.8. Atomic force microscopy (AFM)
AFM is a surface imaging tool that allows high resolution imaging
and scanning of surfaces revealing molecular structures at the nanoscale
[48]. Supported lipid bilayers are appropriate models of membranes as
they have similar lateral diffusion coefﬁcients to free-standing bilayers
such as liposomes [49,50]. Supported lipid bilayers were formed by
vesicular rupture using 2 mM CaCl2. To obtain uniform and defect free
bilayers freshly cleavedmicawas immersed in 200 μMDOPC or DOPG li-
posomes in 10 mMsodiumphosphate, 2 mMCaCl2 at pH-7.4 for 4 h and
then washed twenty times with fresh sodium phosphate buffer without
CaCl2 to remove the calcium. AFMmeasurements were performed using
a Nanoscope IIIa MultiMode AFM from Veeco (Santa Barbara, CA, USA).
Imaging was done in tapping mode using V-shaped silicon nitride tips
with a nominal spring constant of 0.58 N/m. AFM measurements were
carried out in environmental mode i.e., in the presence of buffer. The
force applied on the samples wasmaintained as low as possible by con-
tinuously adjusting the amplitude set point during scanning. Image
analysis was performed using NanoScope 6.14R1 software and all im-
ages are presented after ﬂattening.
3. Results and discussion
3.1. Binding afﬁnity with membrane
Strong binding between AMPs and microbial membranes is one of
the major driving factors for antimicrobial activity [12,51]. Isothermal
titration calorimetry (ITC) is a well-established technique to study
the interaction of antimicrobial peptides with membranes [1,52–55]
yielding thermodynamic parameters such as binding constants, enthal-
py, entropy, free energy and binding stoichiometry. ITC was used to in-
vestigate the thermodynamic parameters of the GL13K interactionwith
DOPC and DOPG model membranes.
Fig. 1 shows typical titration curves for DOPG into GL13K in
10 mM sodium phosphate buffer in the presence or absence of NaCl.
This salt concentration is slightly lower than physiological salt conditions
but high enough for reduced electrostatic interactions and alterations of
peptidemembrane interactions [56–58]. Both titration curves show sim-
ilar behavior, however in the presence of salt, less peptide binds overall
(lower molar ratio at saturation). Also, in the absence of salt, when elec-
trostatic interactions are least shielded, enthalpy changes remain high
with initial injections whereas in the presence of salt the enthalpy de-
creases with each subsequent injection. Thermodynamic parameters
are summarized in Table 1. The interaction of GL13K with DOPG lipo-
somes both in the presence or absence of NaCl yields binding constants
in the order of 106 to 107 suggesting strong binding in both cases.
A B
Fig. 1. ITC binding isotherms for the titration of (1 mM) DOPG into (0.1 mM) GL13K with molar ratio of lipid/peptide. (A) Titration done in 10 mM, pH-7.4 sodium phosphate buffer,
(B) titration done in 107 mM NaCl, 10 mM, pH-7.4 sodium phosphate buffer. Small aliquots DOPG liposomes were sequentially injected into a GL13K solution.
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occurs, these binding constants can be considered an indication of the
partitioning of the peptide to the lipid membrane. The interaction of
GL13K with DOPG bilayers is an endothermic process with high positive
enthalpy changes. This overall enthalpy is a sum of the enthalpy changes
due to a large number of processes such as binding of the peptide to the
membrane, aggregation, surface adsorption or insertion, transformation
of secondary structure and membrane lipid reorganization or lysis. Free
energy changes comprising endothermic enthalpies and large entropic
increases have been reported to be associated with processes involving
high disordering of lipid membranes [1,53,55] although one cannot ex-
clude the solvent entropy changes due to partial dehydration of the pep-
tide hydrophobic face. The large binding constant values and highly
negative free energy values suggest a strong binding of GL13K to DOPG
vesicles in both absence and presence of NaCl. The higher ionic strength
buffer represents the isotonic level required for the carboxyﬂuorescein
experiments. The NaCl concentrations are comparable to physiological
conditions and thus GL13K seems to be potentially active even at physi-
ological salt conditions, consistentwith antibacterial activity data [26]. In
the above experiments, liposomes were added to an excess of peptide in
solution. In this process, the low lipid/peptide ratio during the ﬁrst few
injections leads to a signiﬁcant excess of peptide thatmust be able to dis-
rupt the membrane barrier function leading to the observed endother-
mic process. These endothermic heat changes decrease slowly until
free peptide and bound peptide reach saturation.Table 1
Thermodynamic parameters of GL13K binding to DOPG liposomes. Values of enthalpy,
entropy and free energy change are calculated by the sum of the respective value for
two sites of binding.
Titrant Amount
of NaCl
(mM)
Total enthalpy
change
ΔH = ΔH1 + ΔH2
(kcal/mol)
Total entropy
change
ΔS = ΔS1 + ΔS2
(kcal/mol/K)
Total free energy
change
ΔG = ΔG1 + ΔG2
(kcal/mol)
Liposomes 0 2.0 0.073 −19
Liposomes 107 1.5 0.070 −19
Peptide 0 2.4 0.037 −8In another set of experiments, GL13Kwas added to an initial excess of
liposomes to probewhether the peptide goes from a surface bound state
to a membrane inserted state prior to disrupting the membrane barrier
[55]. For some peptides, a heat proﬁle transition from exothermic to en-
dothermic has been observed upon going from a surface bound state to a
membrane inserted state [54], if the concentration range for these two
states is sufﬁciently well separated. As seen in Fig. 2(A), GL13K initially
binds to the excess of liposomeswithout any signiﬁcant changes in bind-
ing enthalpy upon sequential injections. This suggests that concentration
dependence for the different processes is sufﬁciently similar such that
the thermodynamic parameters for individual processes cannot easily
be resolved. Minimal heat changes were observed (Fig. 2(B)) upon se-
quential addition of DOPC (zwitterionic) liposomes to GL13K indicating
minimal or weak binding to eukaryotic membranes.
3.2. Secondary structure of GL13K
AMPs can adopt a stable secondary structure upon interactionwith a
membrane thereby allowing peptides to better accommodate in the hy-
drophobic environment ofmembranes. This property of AMPs has been
reported to be associatedwith their antimicrobial activity [59] and often
involves formation of an amphipathic structure enabling partitioning to
the hydrophobic bilayer core. Furthermore, AMPs can adapt different
conformations depending on the membrane environment to which
they are exposed [54].
The secondary structure of GL13K in buffer and in the presence of
DOPC and DOPG liposomes was investigated using circular dichroism
(shown in Fig. 3); secondary structure analysis was performed using
SELCON3 [60–63]. GL13K is predominantly unstructured (90%) in
phosphate buffer and does not transform its secondary structure
upon incubation with DOPC liposomes. However, in the presence of
DOPG liposomes, a strong minimum at 217 nm suggests that GL13K
adopts a stable β-sheet structure. An analysis of the spectra indicated
that approximately 60% of the peptide transformed from unstructured
to β-sheet, while the remaining 40% of the peptide was unchanged.
Electrostatic interactions lead to a strong binding with negatively
charged membranes which results in a secondary structure change.
A B
Fig. 2. ITC binding isotherm for (A) titration of (1 mM) GL13K into (0.1 mM) DOPG contained in the reaction chamber, (B) titration of (1 mM) DOPC into (0.1 mM) GL13K peptides
in the reaction chamber.
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needs to be reached in order to adopt a stable secondary structure
upon interaction with membranes [13,64]. Moreover, a peptide can
adopt different conformations in the bulk, surface bound, aggregated
and membrane-inserted states [55]. The CD spectrum represents the
equilibrium between all these states upon interaction withmembranes
[55]. To better understand this mechanism or possibility for GL13K to
adopt different conformations, a ﬁxed concentration of GL13K was in-
cubated with varying concentrations of liposomes of DOPC and DOPG
ranging from a P/L ratio of 1/15 to 1/2.5. No signiﬁcant changes in the
CD spectra were observed with incremental increases in lipid concen-
tration for both the DOPC and DOPG membranes as seen in Fig. 4(A)
and (B). This shows that conformational (secondary structure) changes
of GL13K upon interaction with membranes are not concentration de-
pendent (within the given range tested) and that the peptide adopts
the same structure in all bound states.Fig. 3. CD spectra of GL13K in buffer (black), DOPC (red) and DOPG (green) liposomes
at P/L ratio 1/2.5.3.3. Membrane integrity
In the bound state AMPs can perturb the membrane barrier leading
to disruption of the membrane potential and efﬂux of cellular contents,
eventually leading to cell death. AMPs are thought to act by any of the
three major mechanisms as outlined in the Introduction section. GL13K
membrane disruption was studied using a carboxyﬂuorescein (CF) leak-
age kinetics assay. Stable and non-leaky liposomes were formed and
yielded no increase in ﬂuorescence intensity (Fig. 5(A)) before addition
of Triton X-100 which served as a control for 100% lysis.
The addition of peptide to the DOPG liposomes with increasing P/L
ratios causes a biphasic release of CF with strong instantaneous release
followed by a slow release phase which plateaus within 10–20 min
depending on the P/L ratio. A similar behavior has been observed for var-
ious other AMPs or other cell penetrating peptides [[65] and references
therein]. This concentration dependent gradient release has been at-
tributed to either the formation of transient channels which are sta-
bilized over time [66,67] or a carpetmechanismofmembrane disruption
[34,54]. The extent of release increases with increasing P/L ratios, ﬁnally
leading to 90–95% release of CF at P/L ratios of 1/2.5 (Fig. 5(B)). GL13K
does not yield any signiﬁcant increase in CF release in case of DOPC lipo-
somes and the percentage CF release is constantwith increasing P/L ratios
indicating that GL13K does not result in signiﬁcant lysis of DOPC mem-
branes. The salt concentrations used in these experiments were close to
physiological salt concentrations further emphasizing that GL13K seems
to have highly selective bacterial membrane lytic activity even in high
ionic strength (see Section 3.1). This appears to be due to strong electro-
static binding and better accommodation in a hydrophobic membrane
environment via β-sheet formation.
3.4. Dynamic light scattering (DLS)
Instant release of CF fromDOPG liposomeswhich reaches saturation
in the ﬁrst fewminutes suggests that GL13K causes membrane lysis ei-
ther by formation of transient pores or a carpet mechanism [67]. A car-
pet mechanism of membrane disruption which causes micellization of
the membrane should signiﬁcantly decrease the size of the liposomes
A B
Fig. 4. CD spectra of GL13K upon incubation with (A) DOPC and (B) DOPG liposomes with varying P/L ratios black (zero), red (1/15), green (1/10), blue (1/10) and cyan (1/2.5).
A B
Fig. 5. (A) Sample set of CF release proﬁles over 60 min upon incubation of CF encapsulating DOPG liposomes with increasing amount of GL13K injected at 2 min. P/L ratios are: 1/20
(red), 1/10 (green), 1/5 (blue) and 1/2.5 (cyan). The black trace shows the absence of peptide followed by 100% leakage and releasewith addition of Triton X-100 at 47 min. (B) Averaged
percentage of carboxyﬂuorescein released upon incubation of GL13K with DOPG (solid red circles) and DOPC (solid black rectangles). Each data point is an average of three different ex-
periments at same P/L ratio with percentage release calculated at time 60 min.
Fig. 6. Hydrodynamic radius of DOPG (red circles) andDOPC (black rectangles) liposomes
with increasing P/L ratio.
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destroyed either by sinking raft or translocation of lipo-peptidemicelles
formed by transient channels. To better understand and distinguish be-
tween these two mechanisms, changes in hydrodynamic diameter of
DOPG and DOPC liposomes were measured in the absence or presence
of GL13K using DLS. Additionally, DLS can be used tomonitor aggregation
or fusion of membranes (corresponding to an increase in hydrodynamic
diameter), which have been cited as mechanisms by which some AMPs
exert their antimicrobial activity [11,68,69].
The size of the liposomes in the absence of GL13K peptides varied
from about 90 nm to 120 nm in diameter between various batches of
extruded liposomes with low polydispersity indices (ranging from
0.07 to 0.12). The incubation of GL13K with DOPC liposomes does not
have an effect on the size of the liposomes (as shown in Fig. 6) or the
polydispersity index. GL13K causes a decrease in size for DOPG lipo-
somes with increasing P/L ratios with as high as 50% of lipids being re-
moved from liposomes at P/L 1/2.5 (Fig. 7). The liposomal diameter of
60–80 nm at the highest P/L ratio as shown in Fig. 6 (which resulted
in almost 90%CF release) suggests that GL13K is not causing the complete
micellization of liposomes and thus does not seem to act via a carpet
mechanism. A partial or local micellization can be envisioned in
which the peptide accumulates and locally removes lipid with a
resealing of a then smaller liposome. This would also explain theobserved increase in reported error and concurrent increase in poly-
dispersity index (as high as 0.24) as the amount of lipid removal
would be a function of the peptide aggregation. Membrane fusion
Fig. 7. Percentage loss of lipid molecules from DOPG (red circles) and DOPC (black
rectangles) liposomes initially used upon interaction with increasing P/L ratio. An approxi-
mate lipid loss is calculated based on assuming a ﬁxed area/lipid molecule neglecting any
packing differences between the inner and outer leaﬂets of a liposomal bilayer.
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3.5. Lipid bilayer ordering
GL13K binding and its effect on SLBs was studied using DPI. First, a
stable and uniform bilayer was deposited on the chip surface beforeA
A
Fig. 8. Real time changes observed in transverse magnetic (TM) polarization (top) and nor
with increasing concentration of GL13K as marked by arrow heads.the injection of GL13K, conﬁrmed by almost stable TM values for at
least 30 min reaching 10 to 17 rad (see Fig. 8). The R.I. value was ﬁxed
at 1.47 to calculate the thickness, mass, birefringence and density for
DOPC and DOPG bilayers as summarized in Table 2. Stable and uniform
bilayerswere treatedwith an increasing amount of GL13K. The thickness
of DOPC bilayers was calculated to be 4.7 ± 0.3 nm which is in good
agreement with the reported thickness of 4.5 nm measured by neu-
tron scattering [42]. The thickness calculated for DOPG bilayers was
3.5 ± 0.4 nmwhich is less than expected (close to DOPC) for a DOPG
bilayer. The densities determined for both lipid bilayers are comparable
(1.01 ± 0.01 g/cm3 for DOPG bilayers and 1.01 ± 0.00 g/cm3 DOPC)
suggesting that the decrease in calculated DOPG bilayer thickness
might be due to incomplete coverage of the chip surface, as density is
calculated as the ratio betweenmass deposited per unit area and thick-
ness. The thickness measured by DPI is the average thickness of the
adsorbed layers over the entire length of the chip calculated from rela-
tive phase shifts in TM and TE polarizations, hence partial coverage will
lead to lower average thicknesses even if the actual bilayer thickness is
the same (Fig. 9). If void spaces are present, the binding of GL13K to the
chip surface adds an extra binding parameter thus complicating data
analysis. GL13K binding afﬁnity for the chip was evaluated by injecting
GL13K at the same rate as it was injected over bilayers and the peptide
was not found to bind even at 16 μM (data not shown). The birefrin-
gence which is directly related to the ordering of lipid molecules was
calculated to be 0.0149 ± 0.0005 and 0.0124 ± 0.0025 for DOPC and
DOPG bilayers respectively, in good agreement with previously reported
values [42,46]. Real time changes in TMandbirefringence values after se-
quential injections of GL13K on DOPC and DOPG bilayers are shown inB
B
malized birefringence changes (bottom) for DOPG (A) and DOPC (B) upon interaction
Table 2
Properties of DOPC and DOPG bilayers. Values are averaged over at least six different
experiments.
Bilayer Thickness
(nm)
Mass
(ng mm−2)
Birefringence Density
(g cm−3)
DOPC 4.67 ± 0.26 4.70 ± 0.23 0.0149 ± 0.0005 1.01 ± 0.00
DOPG 3.47 ± 0.39 3.30 ± 0.54 0.0124 ± 0.0025 1.00 ± 0.01
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lipid bilayer coverage to highlight step changes with added peptide.
No signiﬁcant changes in TM and birefringence for DOPG bilayers
were observed for GL13K injections of 6 μM and less. Small changes at
8 μM peptide suggest an initial binding of GL13K. At 10 μM and 12 μM,
themass increaseswhereas the birefringence decreases signiﬁcantly. At
the higher peptide concentrations, it is evident from Fig. 8 that upon the
completion of each injection, changes in TM,mass and birefringence are
irreversible, the result of a strong interaction and binding, which leads
to a permanent disordering of DOPG bilayers by GL13K [40,41]. Large
changes at 10 μM and 12 μM are then followed by gradual changes
suggesting a saturation of the surface [38,39]. A decrease in adsorbed
mass is often correlated to lipid loss from the surface [40,41]. In this
case, a mass increase is observed (Fig. 10 (A)), however it should be
noted that the molecular mass of GL13K is 1423.9 g mol−1 almost
twice that of DOPG therefore themass increase at higher GL13K concen-
trationmight be due to a combination of both adsorbed peptide and loss
of lipid molecules caused by an excess of adsorbed GL13K.
The injection proﬁles (Fig. 8) for peptide addition to DOPC bilayers
show a weak interaction evidenced from the small net change in TM
values (and hence mass and birefringence) occurring for injections at
6 and 8 μM. In addition, for these injections the TM values initially in-
crease upon injection (indicative of binding) and then decrease towards
the pre-injection value as the peptide is washed off by the incoming
buffer. A small increase in mass with a corresponding small decreaseFig. 9. Schematic representation of partial and complete coverage of a chip surface by a phos
surface by lipid bilayers of the same composition.in birefringence (Fig. 10(B)) has been suggested previously to be due
to surface binding of the peptide [40,41].
Although the overall trend for both DOPC and DOPG looks similar
as shown in Fig. 10, it should be noted that the relative mass changes
for DOPC (≈0.1 ng/mm2) compared to DOPG (≈1.08 ng/mm2) are
very small. The normalized birefringence plots in Fig. 8 also show a
signiﬁcantly lower birefringence change for DOPC bilayers compared
to DOPG indicative of permanent and irreversible changes in the mem-
brane ordering of DOPG bilayers and a minimal effect on bilayer order-
ing for a surface bound state of GL13K with DOPC bilayers [40,41].3.6. Visualization of membrane perturbation by GL13K
Atomic force microscopy provides detailed information about the
topography of membranes or other surfaces, and can distinguish
height features down to 1 nm [48]. Smooth, uniform bilayers of ap-
proximately 4 nm height comprising either DOPG or DOPC (as seen
in Fig. 11(A)) were deposited by liposomal rupture on freshly cleaved
mica. When very low concentrations of GL13K (0.5 μM) were added
to DOPG, no changes in membrane topography or adsorption of pep-
tide on the surface were observed (data not shown). Increasing the
GL13K concentration to 1 μMas shown in Fig. 11(B) disruptedmembrane
lipid structure and ordering, causing 1 nm to 2 nm deep troughs on the
membrane surface. However, a more detailed scan (0.5 μm × 0.5 μm)
of theDOPGbilayer incubatedwith 1 μMGL13K clearly showsmembrane
thinned regionswhere a portion of the lipidmolecules has been removed
(Fig. 11(C)). Thesemembrane thinned regions appear since the SLBs have
not resealed upon material/lipid loss possibly due to steric constraints
arising from substrate coupling [70]. A further increase in the concen-
tration of GL13K to 2 μM leads to an increased number of membrane
perturbations and loss of lipids (data not shown). This loss of lipids cor-
relates with the high disordering of DOPG observed using DPI (refer to
Section 3.5).pholipid bilayer. h1 and h2 are thicknesses for partial and complete coverage of the chip
A B
Fig. 10. Changes in mass and birefringence for (A) DOPG and (B) DOPC SLBs with increasing concentration of GL13K.
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but strands (approximately 1 nm high) were observed on the surface
as shown in Fig. 11(D). Even with higher concentrations (up to 4 μM
peptide), only the density of strands increased without membrane thin-
ning (data not shown). This is in agreementwith the small changes in bi-
refringence observed in the DPI experiments (refer to Section 3.5) and
can be attributed to surface bound GL13K peptide strands/aggregates.
An important question that arises iswhy there is no orminimal evidenceFig. 11. Sample AFM images of (A) DOPG andDOPC SLBs in the presence of buffer, (B) DOPG SLB
scan of a DOPG SLB incubated with 1 μM GL13K to better visualize and understand the changeof binding between GL13K and DOPC liposomes, yet AFM and DPI indi-
cate an interaction between GL13K and DOPC supported lipid bilayers.
There are a number of possible causes. Firstly, this might be an effect of
different membrane potentials for liposomes and SLBs. For SLBs these
can arise from different dielectric values between the inside (facing the
substrate) and outside of the membrane resulting from the organization
of entrapped water molecules, as the water layer between the solid sup-
port and bilayer is only a fewwatermolecules thick [71–73]. Additionally,incubatedwith 1 μMGL13K, 1 nm–2 nmdeep darker regionswere observed, (C) smaller
s in DOPG bilayer, and (D) DOPC SLB incubated with 2 μM GL13K.
Fig. 12. Schematic of the GL13K membrane disruption mechanism, (left) planar supported bilayer, (center) GL13K interacts with lipid head groups and (right) after reaching a
threshold concentration, GL13K causes membrane destabilization by removing parts of it forming peptide lipid micelles or stable supramolecular structures.
2202 V. Balhara et al. / Biochimica et Biophysica Acta 1828 (2013) 2193–2203this might be due to non speciﬁc binding of GL13K to small membrane
defects present in the DOPC bilayers [74] and/or differences in the
curvature of the membrane between liposomes and SLBs [18]. Liposo-
mal membrane interaction studies have been compared often to SLBs
due to their similar lateral diffusion rate constants and ﬂuidity [75].
Over the last decade, increasing the spacing and water molecule reten-
tion between SLBs and substrates by using hydrophilic polysaccha-
ride and polymeric cushions such as dextran, poly (L-lactide acid),
silane-polyethylene glycol and polydopamine have gained signiﬁcant
interest as potential biomimetic models [70,73,76,77]. Resolving the ef-
fects of membrane potential, curvature, ﬂuidity and defects on peptide
and protein interactions with model membranes is an area which
must be addressed in the future.
4. Conclusion
Selective toxicity for bacterial cells and fast killing actionwith a broad
antimicrobial spectrum and limited or no resistance are key properties
for antimicrobial peptides. Here, we studied for the ﬁrst time the mem-
brane interaction/disruption mechanism for the antimicrobial peptide
GL13K derived from hPSP. The relatively small size and bactericidal
effects of GL13K on planktonic and bioﬁlm [26] bacteria makes it an at-
tractive antibiotic candidate. Liposomes and SLBs of DOPC and DOPG
lipids were used as model for eukaryotic and bacterial membranes, re-
spectively, to study the role of electrostatic and hydrophobic interactions
on activity and speciﬁcity of GL13K. Calorimetric and CF leakage studies
show that GL13K has a very strong binding afﬁnity and lytic activity
against DOPG liposomes even at high salt concentrations without any
signiﬁcant binding to DOPC liposomes even in low salt conditions. The
strong membrane lytic activity of GL13K at high salt conditions makes
it an interesting candidate for treating diseases such as cystic ﬁbrosis
which generates a high local salt concentration [78]. This high salt con-
centration has been shown to render some host and synthetic AMPs
such as β-defensins ineffective [56]. Furthermore, the concentrations re-
quired to disrupt the model membranes was of the same order of mag-
nitude (μM) as the MIC values reported for Escherichia coli (4 μM or
5 μg/mL) and P. aeruginosa (6 μM or 8 μg/mL) [26].
The activity and selectivity of GL13K are due to a ﬁne balance of its
cationic and amphipathic nature. Electrostatic interactions are involved
in its strong initial binding to the membrane and the β-sheet formation
by GL13K upon interaction with negatively charged DOPG membranes
allows it to better accommodate in the hydrophobic environment of
the membrane. The concentration dependent and instant release of CF
from DOPG liposomes suggests lysis by either a carpet mechanism or
by the formation of transient channels or both. For GL13K–DOPG interac-
tions, the release of liposomal contents appears to be due to a localized
removal of lipid from the membrane via peptide-induced micellization;
excessive lateral stress on the bilayer as the peptide adsorbs or inserts
causes a localized destabilization of the membrane. To reduce excessivelateral stress and decrease the free energy of the system, a part of the
lipids is released along with the peptide as small micelles leading to
the loss of cellular contents by the formation of transient channels
which causes bacterial cell death as depicted in Fig. 12.
In vitro cell studies have shown that GL13K is active against both
Gram-negative and Gram-positive bacteria with the capability to kill
even bioﬁlm forming bacteria. Here, we showed that electrostatics
play amajor role in governing GL13K selectivity for bacterial membranes.
GL13Kdisruptsmembrane barrier function through apartialmicellization
and transient pore mechanism.
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